AHG Company Profile and Key Details

AHG has shown mixed momentum, losing -1.3% over the past week and -7.32% over the past quarter, though year-to-date performance is down -7.32%. Short-term trend indicators are bullishly aligned (SMA20 -1.47%, SMA50 -1.67%, SMA200 -10.43%). The stock’s 14-day RSI is 48.9 (neutral), while the ATR of 0.14 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -33.33% below its high and over 68.47% above its low. Average 10-day trading volume of 12.88 thousand shares is below the 3-month average of 123.10 thousand, indicating normal recent market interest.

Akso Health Group has 854.04 million shares outstanding. This equals 27.58 thousand shares. The short ratio is 0.26 days. Institutional investors hold 151.0% of the float. Insiders own 0.0%. HIGBY LAWRENCE M holds 154.77 thousand shares, TOUPS JOHN M has 24.17 thousand shares and RYLES GERALD F has 6.30 thousand shares.

Akso Health Group generated EPS of -$0.47 over the past year. Five-year average earnings growth is 35.9%.

Akso Health Group last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.58. This means the shares are trading below this model’s fair value.

Akso Health Group (NASDAQ:AHG) closed at $1.21 USD, gaining $0.05 (4.31%) from the previous close of $1.16. The stock is currently mid-range between its 52-week high and low $1.07 and $2.50. With a market capitalization of about $114.62 million, Akso Health Group is classified as a micro-cap and shows lower-than-market volatility (beta ~-1.02). Key stats such as the average daily volume over the past year has been around 125.42 thousand shares, volume is running light vs its 52-week average. Headquartered in Qingdao, None, Akso Health Group operates in the Financial Services sector and the Financial - Credit Services industry. Led by CEO Yilin Wang, the company employs approximately 9 people and listed since November 03, 2017. Akso Health Group, based in Beijing, China, operates a mobile social e-commerce platform targeting the Chinese market.

Akso Health Group trades at a P/E ratio of -3.08, slightly below the S&P 500 average, with a price-to-sales ratio of 15.04 and a price-to-book ratio of 2.09 suggesting the stock is closer to book value. The P/FCF stands at 19.66, also below market averages.

Our AI price prediction model suggests that Akso Health Group stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -19.01%, with price expected at $0.98 by June 29, 2026, within a range of $0.85 to $1.12 3-Month Outlook: Projected rise of 12.4%, reaching $1.36 by September 11, 2026, with a range of $1.09 to $1.51. 1-Year Outlook: Projected gain of 1570.25%, with price at $20.21 by June 15, 2027, within a range of $20.89 to $21.83.

Akso Health Group (NASDAQ:AHG) shares are flat -7.32% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Akso Health Group trading at a premium to the broader market with a P/E of -3.08. Our AI forecast model points to short-term weakness (-19.01% over two weeks), a medium-term rise (12.4% over three months), and a longer-term gain (1570.25% over one year), with expected trading ranges indicating moderate volatility.